Shield AI, Republic of Singapore Air Force, and Defence Science and Technology Agency Expand Partnership to Progressively Field Autonomy Capabilitiesby BangkokStyle05/02/2026PR Newswire
LifeZoom Introduces the Oclux Red Light Eye Mask–A Naturally Restorative, Aesthetics-Driven Solution for the Effects of Screen-Based Lifeby BangkokStyle05/02/2026PR Newswire
iQIYI Original “Running Man Thailand” Set to Ignite Global Screens with Star-Studded Lineup and Non-Stop Surprisesby BangkokStyle05/02/2026PR Newswire
Sore Back After Pre-New Year Cleaning? Herbalgy’s “Wellness Declutter” Method Shares 3 Tips to Sweep Away Pain for a Light, Energetic New Yearby BangkokStyle05/02/2026PR Newswire
NYSE Content Update: Bob’s Discount Furniture + Forgent Power Solutions to Debut for Tradeby BangkokStyle05/02/2026PR Newswire
Mantle’s Evolution Into an Institutional Distribution Layer for Onchain Finance, Marked by 37% QoQ TVL Growth in Messari Reportby BangkokStyle05/02/2026PR Newswire
Cloopen Announces Changes to Board of Directors and Committee Membershipby BangkokStyle05/02/2026PR Newswire
Bounteous Launches Claude Code Lab Series in Partnership with Anthropic to Accelerate Responsible AI Adoptionby BangkokStyle05/02/2026PR Newswire
A Subsidiary of AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C to Serve as an Event Coordinator for 2026 Middle East Consumer Electronics Showby BangkokStyle05/02/2026PR Newswire
Global Times: China’s No.1 central document in starting year of 15th Five-Year Plan sets agricultural modernization roadmap, turning rural potential into growth momentumby BangkokStyle05/02/2026PR Newswire
Iron Software Sees 200% Increase in Agentic AI Adoption for HTML to PDF C# Workflows with IronPDFby BangkokStyle05/02/2026PR Newswire
DIFC’s landmark 2025 results solidify Dubai’s position as a leading global destination for finance and businessby BangkokStyle05/02/2026PR Newswire
Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansionby BangkokStyle05/02/2026PR Newswire
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indicationsby BangkokStyle05/02/2026PR Newswire
